Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1.
Hirotsugu MaekawaShunsuke KawaiMegumi NishioSanae NagataYonghui JinHiroyuki YoshitomiShuichi MatsudaJunya ToguchidaPublished in: Orphanet journal of rare diseases (2020)
Our study suggested that prophylactic treatment will be a choice of method for the clinical application of rapamycin for FOP.